Cargando…
Mycoplasma genitalium in the US (MyGeniUS): Surveillance Data From Sexual Health Clinics in 4 US Regions
BACKGROUND: Mycoplasma genitalium (MG) is on the CDC Watch List of Antimicrobial Resistance Threats, yet there is no systematic surveillance to monitor change. METHODS: We initiated surveillance in sexual health clinics in 6 cities, selecting a quota sample of urogenital specimens tested for gonorrh...
Autores principales: | Manhart, Lisa E, Leipertz, Gina, Soge, Olusegun O, Jordan, Stephen J, McNeil, Candice, Pathela, Preeti, Reno, Hilary, Wendel, Karen, Parker, Anika, Geisler, William M, Getman, Damon, Golden, Matthew R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10654846/ https://www.ncbi.nlm.nih.gov/pubmed/37402645 http://dx.doi.org/10.1093/cid/ciad405 |
Ejemplares similares
-
Distribution of Macrolide Resistant Mycoplasma genitalium in Urogenital Tract Specimens From Women Enrolled in a US Clinical Study Cohort
por: Getman, Damon, et al.
Publicado: (2022) -
163. High Prevalence of Urogenital and Rectal Mycoplasma genitalium in U.S. MSM with a History of STIs in the Last Year
por: Bainbridge, Emma D, et al.
Publicado: (2021) -
Azithromycin and Doxycycline Resistance Profiles of U.S. Mycoplasma genitalium Strains and Their Association with Treatment Outcomes
por: Wood, Gwendolyn E., et al.
Publicado: (2021) -
Characteristics of Mycoplasma genitalium Urogenital Infections in a Diverse Patient Sample from the United States: Results from the Aptima Mycoplasma genitalium Evaluation Study (AMES)
por: Manhart, Lisa E., et al.
Publicado: (2020) -
Weighing Potential Benefits and Harms of Mycoplasma genitalium Testing and Treatment Approaches
por: Manhart, Lisa E., et al.
Publicado: (2022)